According to Adicet Bio's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$69.72 M a decrease over its 2021 earnings that were of -$61.95 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.15 B | 104.61% |
2022 | -$69.72 M | 12.53% |
2021 | -$61.95 M | 57.39% |
2020 | -$39.36 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -6,716.94% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -2,390.48% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -2,227.82% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.40 B | -383.94% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | $99.33 M | -169.64% | ๐บ๐ธ USA |
Quaker Houghton KWR | $0.20 B | -242.90% | ๐บ๐ธ USA |